Skip to main content

View full-text article in PMC

. 2012 May 28;14(4):604–611. doi: 10.1038/aja.2011.178

Table 3. Biochemical parameters with significant increases between placebo and active treatment arm (Nebido).

Variables	Placebo		Nebido
	Baseline	48 weeks	Baseline	48 weeks	F	P
	Mean±s.d.	Mean±s.d.	Mean±s.d.	Mean±s.d.
PSA (ng ml⁻¹)	0.9±0.8	1.1±1.0	0.8±0.6	1.2±1.0	4.789	0.011
Haematocrit (%)	43.4±2.8	43.2±3.1	43.1±3.4	48.7±4.4	53.149	<0.001
Total bilirubin (μmol l⁻¹)	11.1±4.4	11.8±4.8	12.3±5.8	15.6±7.0	12.295	0.001

Abbreviation: PSA, prostate-specific antigen.